دوار مرض مينيير غير المسيطر عليه بالستيرويد عبر الطبلة: ما الخطوة التالية؟

References

• Clinicians should offer, or refer to a clinician who can offer, intratympanic (IT) gentamicin to patients with active Ménière's disease not responsive to nonablative therapy.
• While there is no specific dosing protocol, the literature supports dosing on a weekly or "as needed" basis, given that there is a lower effect on hearing as compared with high-dose or infusion therapy.
• The goals of MD treatment are to prevent or at least reduce the severity and frequency of vertigo attacks.